Join us at Autism Ontario’s next Signature Series live interview with leading Canadian autism researchers Dr. Stephen Scherer, Chief of Research at The Hospital for Sick Children (SickKids), and Dr. Evdokia Anagnostou, Vice President of Research and Director of Holland Bloorview Research Institute, for a reflective and insightful conversation on what the science tells us, and how families can confidently navigate new information as it emerges. 

Together, they’ll explore how autism research is conducted, what science tells us today, and how parents can evaluate the information they see online. The discussion will also tackle common myths and misinformation from outdated theories to the latest viral claims, all while helping families understand what makes an intervention truly evidence-based. 

Through an open and accessible conversation, this Signature Series episode will:

• Explore what is currently known about autism, including genetics, environmental factors, and the diversity of autism.
• Learn strategies to evaluate information and recognize misinformation, including key considerations when assessing what is best for your family.
• Discuss how evidence-based interventions are validated and translated into meaningful support for autistic individuals and their families.

Why You Should Attend Live 
Parents and caregivers will have a chance to submit their questions to both experts, making this an interactive opportunity to hear directly from Dr. Evdokia Anagnostou and Dr. Stephen Scherer —two of Canada’s most respected voices in autism research.   

Don’t miss this unique opportunity to hear a live conversation that cuts through the noise and brings clarity to what’s real, what’s changing, and where to place your trust. 

 
Register now to secure your spot for this exclusive Autism Ontario event. This event is designed to be accessible, empathetic, and empowering, because informed families make stronger choices.

Can’t make it? Don’t worry! After the live event, Signature Series webinars are available On-Demand. Register now to receive your access link! 

Meet our Speakers:

Dr. Stephen Scherer, PhD DSc FRSC, Chief of Research, The Hospital for Sick Children (SickKids) and Director, McLaughlin Centre, University of Toronto.

Dr. Stephen Scherer, PhD DSc FRSC is Chief of Research and holds the Northbridge Chair in Paediatric Research at The Hospital for Sick Children (SickKids) and University of Toronto (UofT) and he is Director of the UofT McLaughlin Centre, as well as The Centre for Applied Genomics at SickKids. His team contributed to the landmark discovery of global gene copy number variation (CNV) as a common form of genetic variation in human DNA. As part of this discovery, he founded the Database of Genomic Variants, which now catalogues >2 million CNVs, and is used to facilitate hundreds of thousands of clinical diagnoses worldwide each year. His team also identified CNV of specific genes involved in brain development to contribute to Autism Spectrum Disorder, demonstrating this complex human behavioural condition can have a biological basis. His research is documented in over 750 scholarly publications and patents.?Dr.?Scherer?has won numerous honors, such as the Steacie Prize, a Howard Hughes Medical Institute Scholarship, the Premier’s Summit Award for Medical Research, the Killam Prize, the Debrecen Award for Molecular Medicine, and multiple Honorary degrees. He is a Fellow of the American Association for the Advancement of Science and the Royal Society of Canada.?In 2014, he was selected as an esteemed Thomson Reuters (now Clarivate) Citation Laureate in Physiology and Medicine for “the discovery of large-scale copy number variation and its association with specific diseases”. 

Dr. Evdokia Anagnostou, MD, FRCPC, Child Neurologist, Vice President of Research and Director of the Bloorview Research Institute and Canada Research Chair in Translational Therapeutics in Autism (Tier II); Dr. Stuart D. Sims Chair in Autism
Dr. Evdokia Anagnostou is a Child Neurologist and Professor of Pediatrics at the University of Toronto, as well as Vice President of  Research at Holland Bloorview Kids Rehabilitation Hospital and Director of the Bloorview Research Institute. As a Senior Clinician Scientist, she co-leads the Autism Research Centre (ARC) at Holland Bloorview and the University of Toronto. She has held the Canada Research Chair in Translational Therapeutics in Autism Spectrum Disorder (ASD). Currently, she holds the Dr. Stuart D. Sims Chair in Autism at Holland Bloorview and the University of Toronto. She is a fellow of the Canadian Academy of Health Sciences. 

Dr. Anagnostou has received extensive international funding to understand the underlying biological differences associated with ASD and other neurodevelopmental differences and translate such understandings into potential novel interventions. She also has funding in health system innovation, partner engagement, and in understanding the meaning and impact of neurodevelopmental conditions in marginalized populations. She has served on multiple government committees on improving diagnostic and intervention pathways, and several editorial boards and grant review panels. She has also been recognized for her contributions to training young clinicians and scientists and for her commitment to women in STEM. She currently represents the region of America-North on the International  Society for Autism Research Global Senior Leaders committee.

 
Disclaimer: Opinions reflected in this webinar are those of the speaker(s) and presenter(s), and do not necessarily reflect Autism Ontario’s views. Please note that Autism Ontario does not endorse any specific therapy, product, treatment, strategy, opinions, service, or individual. We do, however, endorse your right to information. Autism Ontario strongly believes that it is important to do your own research and make your own informed decisions.